Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IYH vs. PRHSX: which is better?

Bottom line

IYH vs PRHSX: the short answer

IYH (iShares U.S. Healthcare ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) share a meaningful slice of their top holdings — about 77% by weight.

But PRHSX is far broader, holding 279 positions to 103 for IYH, so beyond the top names it adds exposure IYH doesn't have.

IYH is cheaper at 0.37% vs 0.83% — a difference of $46 a year per $10,000 invested.

Over five years, IYH returned +7.0% a year vs +4.2% for PRHSX.

Updated Nov 19, 2026

IYH vs PRHSX side by side

IYHPRHSX
TypeETFMutual fund
Fund familyiSharesT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.37%0.83%
Annual cost per $10k$37$83
10-yr cost on $10k (prospectus)$468$1,025
Max front loadNone—
12b-1 fee0%—
1-yr return+13.1%+17.7%
5-yr return (annualized)+7.0%+4.2%
10-yr return (annualized)+9.4%+9.1%
Best quarter+15.3%+23.5%
Worst quarter−12.7%−15.8%
Net assets (fund)$3.6B$11.9B
Number of holdings103279
Portfolio turnover3%62%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIYHPRHSXDifference
2025+13.1%+17.7%−4.6%
2024+3.1%+1.8%+1.3%
2023+2.1%+3.1%−1.0%
2022−4.4%−12.2%+7.8%
2021+23.4%+13.3%+10.1%
2020+15.5%+30.1%−14.6%
2019+20.8%+29.1%−8.3%
2018+5.9%+1.2%+4.6%
2017+22.3%+28.0%−5.6%
2016−2.8%−10.4%+7.5%

Source: Fund prospectus bar charts

Holdings overlap

15 of IYH's top 25 holdings also appear in PRHSX's top 25.

Shared top holdings
HoldingIYHPRHSX
Eli Lilly And Company15.11%14.28%
Johnson & Johnson10.17%6.63%
Abbvie Inc.7.32%5.10%
Unitedhealth Group Incorporated6.16%5.99%
Merck & Co., Inc.5.31%4.01%
Thermo Fisher Scientific Incorporated3.52%2.52%
Amgen Inc.3.42%1.82%
Abbott Laboratories3.02%1.89%
Gilead Sciences, Inc.2.66%2.82%
Bristol-myers Squibb Company2.20%2.11%
Intuitive Surgical, Inc.2.05%1.87%
Danaher Corporation2.03%1.43%
Vertex Pharmaceuticals Incorporated2.00%2.28%
Stryker Corporation1.86%1.78%
Elevance Health, Inc.1.34%1.53%

Source: SEC Form N-PORT

IYH top 10

  1. Eli Lilly And Company — 15.11%
  2. Johnson & Johnson — 10.17%
  3. Abbvie Inc. — 7.32%
  4. Unitedhealth Group Incorporated — 6.16%
  5. Merck & Co., Inc. — 5.31%
  6. Thermo Fisher Scientific Incorporated — 3.52%
  7. Amgen Inc. — 3.42%
  8. Abbott Laboratories — 3.02%
  9. Gilead Sciences, Inc. — 2.66%
  10. Pfizer Inc. — 2.35%

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

FAQ

What is the difference between IYH and PRHSX?
IYH (iShares U.S. Healthcare ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) share a meaningful slice of their top holdings — about 77% by weight. But PRHSX is far broader, holding 279 positions to 103 for IYH, so beyond the top names it adds exposure IYH doesn't have.
Which is cheaper, IYH or PRHSX?
IYH has the lower expense ratio (0.37%).
Should I own both IYH and PRHSX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.